Amifostine has the potential to induce haematologic responses and decelerate disease progression in individual patients with low- and intermediate-1-risk myelodysplastic syndromes. (Q46027663)
Jump to navigation
Jump to search
scientific article published on 2 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Amifostine has the potential to induce haematologic responses and decelerate disease progression in individual patients with low- and intermediate-1-risk myelodysplastic syndromes. |
scientific article published on 2 May 2009 |
Statements
1 reference
Amifostine has the potential to induce haematologic responses and decelerate disease progression in individual patients with low- and intermediate-1-risk myelodysplastic syndromes. (English)
1 reference
Julie Schanz
1 reference
Heike Jung
1 reference
Bernhard Wörmann
1 reference
Winfried Gassmann
1 reference
Thomas Petersen
1 reference
Axel Hinke
1 reference
Detlef Haase
1 reference
2 May 2009
1 reference
1 reference
33
1 reference
9
1 reference
1183-1188
1 reference